Barr Receives Tentative Approval For Generic KYTRIL(R) Tablets, 1mg (Base)

Sat, 20 Jan 2007 02:00 PM EST

... Barr Pharmaceuticals, Inc. (NYSE: BRL) today announced that its subsidiary, Barr Laboratories, Inc. has received tentative approval from the U.S. Food and Drug Administration (FDA) for its generic version of Roche Laboratories Inc.'s KYTRIL(R) (granisetron hydrochloride) Tablets, 1mg (base). [click link for full article] ...